- Arvinas (New Haven, CT)
- …from debilitating and life-threatening diseases through the discovery, development , and commercialization of therapies that degrade disease-causing proteins. ... The company is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for… more